Future of nonnucleoside reverse transcriptase inhibitors

被引：15
作者：
Sluis-Cremer, Nicolas [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Dept Med, Pittsburgh, PA 15261 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2018年 / 115卷 / 04期
基金：
美国国家卫生研究院;
关键词：
LONG-ACTING RILPIVIRINE; HIV PREVENTION; SAFETY; TRIAL;
D O I：
10.1073/pnas.1720975115
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：637 / 638
页数：2
相关论文
共 13 条
  • [1] Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
    Baeten, J. M.
    Palanee-Phillips, T.
    Brown, E. R.
    Schwartz, K.
    Soto-Torres, L. E.
    Govender, V.
    Mgodi, N. M.
    Kiweewa, F. Matovu
    Nair, G.
    Mhlanga, F.
    Siva, S.
    Bekker, L. -G.
    Jeenarain, N.
    Gaffoor, Z.
    Martinson, F.
    Makanani, B.
    Pather, A.
    Naidoo, L.
    Husnik, M.
    Richardson, B. A.
    Parikh, U. M.
    Mellors, J. W.
    Marzinke, M. A.
    Hendrix, C. W.
    van der Straten, A.
    Ramjee, G.
    Chirenje, Z. M.
    Nakabiito, C.
    Taha, T. E.
    Jones, J.
    Mayo, A.
    Scheckter, R.
    Berthiaume, J.
    Livant, E.
    Jacobson, C.
    Ndase, P.
    White, R.
    Patterson, K.
    Germuga, D.
    Galaska, B.
    Bunge, K.
    Singh, D.
    Szydlo, D. W.
    Montgomery, E. T.
    Mensch, B. S.
    Torjesen, K.
    Grossman, C. I.
    Chakhtoura, N.
    Nel, A.
    Rosenberg, Z.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) : 2121 - 2132
  • [2] Distinct Pharmacodynamic Activity of Rilpivirine in Ectocervical and Colonic Explant Tissue
    Dezzutti, Charlene S.
    Else, Laura J.
    Yandura, Sarah E.
    Shetler, Cory
    Russo, Julie
    Back, David J.
    McGowan, Ian
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 2765 - 2770
  • [3] First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics
    Friedland, Barbara A.
    Hoesley, Craig J.
    Plagianos, Marlena
    Hoskin, Elena
    Zhang, Shimin
    Teleshova, Natalia
    Alami, Mohcine
    Novak, Lea
    Kleinbeck, Kyle R.
    Katzen, Lauren L.
    Zydowsky, Thomas M.
    Fernandez-Romero, Jose A.
    Creasy, George W.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (05) : 489 - 496
  • [4] Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial
    Guay, LA
    Musoke, P
    Fleming, T
    Bagenda, D
    Allen, M
    Nakabiito, C
    Sherman, J
    Bakaki, P
    Ducar, C
    Deseyve, M
    Emel, L
    Mirochnick, M
    Fowler, MG
    Mofenson, L
    Miotti, P
    Dransfield, K
    Bray, D
    Mmiro, F
    Jackson, JB
    [J]. LANCET, 1999, 354 (9181) : 795 - 802
  • [5] Long-acting rilpivirine for HIV prevention
    Jackson, Akil
    McGowan, Ian
    [J]. CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 253 - 257
  • [6] CRYSTAL-STRUCTURE AT 3.5 ANGSTROM RESOLUTION OF HIV-1 REVERSE-TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR
    KOHLSTAEDT, LA
    WANG, J
    FRIEDMAN, JM
    RICE, PA
    STEITZ, TA
    [J]. SCIENCE, 1992, 256 (5065) : 1783 - 1790
  • [7] From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection
    Kudalkar, Shalley N.
    Beloor, Jagadish
    Quijano, Elias
    Spasov, Krasimir A.
    Lee, Won-Gil
    Cisneros, Jose A.
    Saltzman, W. Mark
    Kumar, Priti
    Jorgensen, William L.
    Anderson, Karen S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (04) : E802 - E811
  • [8] Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
    Kudalkar, Shalley N.
    Beloor, Jagadish
    Chan, Albert H.
    Lee, Won-Gil
    Jorgensen, William L.
    Kumar, Priti
    Anderson, Karen S.
    [J]. MOLECULAR PHARMACOLOGY, 2017, 91 (04) : 383 - U168
  • [9] Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment
    McGowan, Ian
    Dezzutti, Charlene S.
    Siegel, Aaron
    Engstrom, Jarret
    Nikiforov, Alexiy
    Duffill, Kathryn
    Shetler, Cory
    Richardson-Harman, Nicola
    Abebe, Kaleab
    Back, David
    Else, Laura
    Egan, Deidre
    Khoo, Saye
    Egan, James E.
    Stall, Ronald
    Williams, Peter E.
    Rehman, Khaleel K.
    Adler, Amy
    Brand, Rhonda M.
    Chen, Beatrice
    Achilles, Sharon
    Cranston, Ross D.
    [J]. LANCET HIV, 2016, 3 (12): : E569 - E578
  • [10] Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women
    Nel, A.
    van Niekerk, N.
    Kapiga, S.
    Bekker, L. -G.
    Gama, C.
    Gill, K.
    Kamali, A.
    Kotze, P.
    Louw, C.
    Mabude, Z.
    Miti, N.
    Kusemererwa, S.
    Tempelman, H.
    Carstens, H.
    Devlin, B.
    Isaacs, M.
    Malherbe, M.
    Mans, W.
    Nuttall, J.
    Russell, M.
    Ntshele, S.
    Smit, M.
    Solai, L.
    Spence, P.
    Steytler, J.
    Windle, K.
    Borremans, M.
    Resseler, S.
    Van Roey, J.
    Parys, W.
    Vangeneugden, T.
    Van Baelen, B.
    Rosenberg, Z.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) : 2133 - 2143
12